GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ABUS · Mar 31, 2026

Arbutus Biopharma Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001447028-26-000021General Corporate

Debt relative to revenue100thOwn-history percentile · N=13

Evidence method

Level · gp.fundamentals.debt_to_revenue

0.00% · OPTIONAL · VALID

Operating cash generation100thOwn-history percentile · N=13

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-4.53% · OPTIONAL · VALID

Revenue growth100thOwn-history percentile · N=9

Evidence method

Yoy · gp.fundamentals.revenue

10054.54% · CORE · VALID

Operating margin100thOwn-history percentile · N=13

Evidence method

Level · gp.fundamentals.operating_margin

94.30% · CORE · VALID

R&D intensity0thOwn-history percentile · N=13

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

2.30% · OPTIONAL · VALID

SBC intensity0thOwn-history percentile · N=13

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

0.76% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History11 statesHistory building

Dec 31, 20230/7 normalizedLevel 3 Mar 31, 20240/7 normalizedLevel 3 Jun 30, 20240/7 normalizedLevel 3 Sep 30, 20240/7 normalizedLevel 3 Dec 31, 20246/7 normalizedLevel 3 Mar 31, 20256/7 normalizedLevel 3 Jun 30, 20256/7 normalizedLevel 3 Sep 30, 20256/7 normalizedLevel 3 Dec 31, 20257/7 normalizedLevel 3 Mar 31, 20266/6 normalizedLevel 3 Jun 30, 20266/6 normalizedLevel 3

Period transition

What moved in the state?

Cash Generation Increased

Previous: -281.45%
Current: -4.53%
Delta: 276.93%

Growth Increased

Previous: 128.21%
Current: 10054.54%
Delta: 9926.32%

Profitability Increased

Previous: -270.96%
Current: 94.30%
Delta: 365.26%

R And D Intensity Decreased

Previous: 179.23%
Current: 2.30%
Delta: -176.93%

Sbc Intensity Decreased

Previous: 49.37%
Current: 0.76%
Delta: -48.61%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · ABUS Fundamental State →Transitioned To · ABUS CASH_GENERATION_INCREASED →Transitioned To · ABUS GROWTH_INCREASED →Transitioned To · ABUS PROFITABILITY_INCREASED →Transitioned To · ABUS R_AND_D_INTENSITY_DECREASED →Transitioned To · ABUS SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.